PITTSBURGH (KDKA) — There’s a new treatment for eczema, that’s offering relief to patients.
Eucrisa was approved by the Food and Drug Administration in December.
It works on the overactive part of the immune system in eczema, a protein called phosphodiesterase.
Before, only a pill could quiet this enzyme.
This new formulation can be absorbed through the skin.
Unlike steroids, it can be used in sensitive areas where the skin may already be thin, such as the face, eye lids, and groin.
And it’s approved for use in kids as young as two.
In studies where it was compared to a plain moisturizer, the rash cleared for only one in five in the comparison group, but one in three using Eucrisa.
Researchers did find one minor side effect.